{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:37:34Z","timestamp":1790642254601,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.phrs.2016.05.001","type":"journal-article","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T09:57:05Z","timestamp":1462442225000},"page":"86-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["ApoA-IMilano phospholipid complex (ETC-216) infusion in human volunteers. Insights into the phenotypic characteristics of ApoA-IMilano carriers"],"prefix":"10.1016","volume":"111","author":[{"given":"Charles L.","family":"Bisgaier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Ackermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendi V.","family":"Rodrigueza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.05.001_bib0005","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/01.ATV.20.5.1185","article-title":"1999 George Lyman Duff memorial lecture: lipid transfer proteins, HDL metabolism, and atherogenesis","volume":"20","author":"Tall","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2016.05.001_bib0010","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/01.CIR.0000012918.84068.43","article-title":"Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors","volume":"150","author":"Sacks","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.05.001_bib0015","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1136\/bmj.39059.438044.DB","article-title":"Pfizer stops clinical trials of heart drug","volume":"333","author":"Tanne","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2016.05.001_bib0020","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1056\/NEJMe078029","article-title":"CETP inhibitors to increase HDL cholesterol levels","volume":"356","author":"Tall","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.05.001_bib0025","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMoa070635","article-title":"Effect of torcetrapib on the progression of coronary atherosclerosis","volume":"356","author":"Nissen","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.05.001_bib0030","first-page":"251","article-title":"Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib","volume":"6","author":"Goldberg","year":"2012","journal-title":"Drug Design Dev. Ther."},{"key":"10.1016\/j.phrs.2016.05.001_bib0035","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/MOL.0000000000000248","article-title":"What does the future hold for cholesteryl ester transfer protein inhibition?","volume":"26","author":"Arsenault","year":"2015","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.phrs.2016.05.001_bib0040","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1161\/01.ATV.0000143389.00252.bc","article-title":"Inhibition of cholesteryl ester transfer protein activity by JTT-705 increases apolipoprotein E-containing high-density lipoprotein and favorably affects the function and enzyme composition of high-density lipoprotein in rabbits","volume":"24","author":"Zhang","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2016.05.001_bib0045","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ahj.2011.11.017","article-title":"Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging study","volume":"163","author":"Ballantyne","year":"2012","journal-title":"Am. Heart J."},{"key":"10.1016\/j.phrs.2016.05.001_bib0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0022-2275(20)42240-0","article-title":"Familial cholesteryl ester transfer protein deficiency is associated with triglyceride-rich low density lipoproteins containing cholesteryl esters of probable intracellular origin","volume":"32","author":"Bisgaier","year":"1991","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2016.05.001_bib0055","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.jacc.2015.09.013","article-title":"Cholesterol efflux capacity and pre-Beta-1HDL concentrations are increased in dyslipidemic patients treated with evacetrapib","volume":"66","author":"Nicholls","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2016.05.001_bib0060","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1194\/jlr.R001610","article-title":"The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?","volume":"51","author":"Vergeer","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2016.05.001_bib0065","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0022-2275(20)32212-4","article-title":"Intravenous apoA-I\/lecithin discs increase pre-beta-HDL concentration in tissue fluid and stimulate reverse cholesterol transport in humans","volume":"42","author":"Nanjee","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2016.05.001_bib0070","first-page":"III86","article-title":"Role of high density lipoproteins in the regression of atherosclerosis","volume":"86","author":"Badimon","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.05.001_bib0075","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/hq0402.105901","article-title":"Elevated soluble cellular adhesion molecules in subjects with low HDL-cholesterol","volume":"22","author":"Calabresi","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2016.05.001_bib0080","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/MOL.0b013e32833bcdc1","article-title":"Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities","volume":"21","author":"Kontush","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.phrs.2016.05.001_bib0085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-2275(20)37433-2","article-title":"The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes","volume":"38","author":"Kuivenhoven","year":"1997","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2016.05.001_bib0090","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/CIRCULATIONAHA.108.848143","article-title":"Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans","volume":"120","author":"Calabresi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.05.001_bib0095","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.atherosclerosis.2008.08.038","article-title":"Functional LCAT is not required for macrophage cholesterol efflux to human serum","volume":"204","author":"Calabresi","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2016.05.001_bib0100","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.ATV.20.3.721","article-title":"Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse","volume":"20","author":"Kozarsky","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2016.05.001_bib0105","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/387414a0","article-title":"Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels","volume":"387","author":"Kozarsky","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.05.001_bib0110","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1172\/JCI25327","article-title":"Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo","volume":"115","author":"Zhang","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2016.05.001_bib0115","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1172\/JCI109956","article-title":"A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family","volume":"66","author":"Franceschini","year":"1980","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2016.05.001_bib0120","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1172\/JCI109957","article-title":"A-Imilano apoprotein: isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins","volume":"66","author":"Weisgraber","year":"1980","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2016.05.001_bib0125","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/CIRCULATIONAHA.107.705657","article-title":"Normal vascular function despite low levels of high-density lipoprotein cholesterol in carriers of the apolipoprotein A-I(Milano) mutant","volume":"116","author":"Gomaraschi","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.05.001_bib0130","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.CIR.103.15.1949","article-title":"Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study","volume":"103","author":"Sirtori","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.05.001_bib0135","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1021\/bi1003734","article-title":"Conformation of dimeric apolipoprotein A-I milano on recombinant lipoprotein particles","volume":"49","author":"Bhat","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.phrs.2016.05.001_bib0140","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0005-2760(88)90011-2","article-title":"Characterization of A-I-containing lipoproteins in subjects with A-I Milano variant","volume":"960","author":"Cheung","year":"1988","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2016.05.001_bib0145","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1074\/jbc.M609336200","article-title":"A unique protease-sensitive high density lipoprotein particle containing the apolipoprotein A-I(Milano) dimer effectively promotes ATP-binding Cassette A1-mediated cell cholesterol efflux","volume":"282","author":"Favari","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.05.001_bib0150","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/S0022-2275(20)34945-2","article-title":"High density lipoprotein particle size restriction in apolipoprotein A-I(Milano) transgenic mice","volume":"38","author":"Bielicki","year":"1997","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2016.05.001_bib0155","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1021\/bi011716p","article-title":"Apolipoprotein A-I(Milano) and apolipoprotein A-I(Paris) exhibit an antioxidant activity distinct from that of wild-type apolipoprotein A-I","volume":"41","author":"Bielicki","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.phrs.2016.05.001_bib0160","doi-asserted-by":"crossref","first-page":"16307","DOI":"10.1021\/bi991246n","article-title":"Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-IMilano dimer","volume":"38","author":"Calabresi","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.phrs.2016.05.001_bib0165","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1161\/hc2501.092494","article-title":"High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization","volume":"103","author":"Shah","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.05.001_bib0170","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/ATVBAHA.107.148403","article-title":"Wild-type ApoA-I and the Milano variant have similar abilities to stimulate cellular lipid mobilization and efflux","volume":"27","author":"Weibel","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2016.05.001_bib0175","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.jacc.2006.07.040","article-title":"Bone marrow transplantation shows superior atheroprotective effects of gene therapy with apolipoprotein A-I Milano compared with wild-type apolipoprotein A-I in hyperlipidemic mice","volume":"48","author":"Wang","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2016.05.001_bib0180","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1172\/JCI116349","article-title":"In vivo metabolism of a mutant form of apolipoprotein A-I, apo A-IMilano, associated with familial hypoalphalipoproteinemia","volume":"91","author":"Roma","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2016.05.001_bib0185","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/01.RES.0000018422.31717.EE","article-title":"Recombinant apolipoprotein A-I(Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks","volume":"90","author":"Chiesa","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2016.05.001_bib0190","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.290.17.2292","article-title":"Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial","volume":"290","author":"Nissen","year":"2003","journal-title":"JAMA: J. Am. Med. Assoc."},{"key":"10.1016\/j.phrs.2016.05.001_bib0195","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1160\/TH12-08-0556","article-title":"Acute ApoA-I Milano administration induces plaque regression and stabilisation in the long term","volume":"108","author":"Giannarelli","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.phrs.2016.05.001_bib0200","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.atherosclerosis.2011.10.006","article-title":"Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL(wild-type)","volume":"220","author":"Ibanez","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2016.05.001_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000176473","article-title":"High density lipoprotein metabolism in a patient with abetalipoproteninemia","volume":"25","author":"Illingworth","year":"1981","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.phrs.2016.05.001_bib0210","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0009-8981(83)90089-X","article-title":"In vivo metabolism of human apoprotein A-I-phospholipid complexes: comparison with human high density lipoprotein-apoprotein A-I metabolism","volume":"131","author":"Malmendier","year":"1983","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"10.1016\/j.phrs.2016.05.001_bib0215","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJM198206243062503","article-title":"Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease","volume":"306","author":"Norum","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.05.001_bib0220","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/01.ATV.16.9.1203","article-title":"Effects of intravenous infusion of lipid-free apo A-I in humans","volume":"16","author":"Nanjee","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2016.05.001_bib0225","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIRCRESAHA.113.301112","article-title":"Pegylation of high-density lipoprotein decreases plasma clearance and enhances antiatherogenic activity","volume":"113","author":"Murphy","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2016.05.001_bib0230","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0022-2275(20)42037-1","article-title":"Rapid on-line determination of cholesterol distribution among plasma lipoproteins after high-performance gel filtration chromatography","volume":"32","author":"Kieft","year":"1991","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2016.05.001_bib0235","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/01.ATV.17.10.2132","article-title":"Large versus small unilamellar vesicles mediate reverse cholesterol transport in vivo into two distinct hepatic metabolic pools. Implications for the treatment of atherosclerosis","volume":"17","author":"Rodrigueza","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2016.05.001_bib0240","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.jacc.2007.12.010","volume":"51","author":"Parolini","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2016.05.001_bib0245","first-page":"729","article-title":"A novel role for ABCA1-generated large pre-beta migrating nascent HDL in the regulation of hepatic VLDL triglyceride secretion","volume":"51","author":"Chung","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2016.05.001_bib0250","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.atherosclerosis.2006.12.027","article-title":"Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification","volume":"196","author":"de Vries","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2016.05.001_bib0255","doi-asserted-by":"crossref","first-page":"9930","DOI":"10.1074\/jbc.M312476200","article-title":"Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein","volume":"279","author":"Favari","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.05.001_bib0260","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1194\/jlr.P016816","article-title":"LDL-apheresis depletes apoE-HDL and pre-beta1-HDL in familial hypercholesterolemia: relevance to atheroprotection","volume":"52","author":"Orsoni","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2016.05.001_bib0265","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.amjcard.2011.03.054","article-title":"Relation of increased prebeta-1 high-density lipoprotein levels to risk of coronary heart disease","volume":"108","author":"Guey","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phrs.2016.05.001_bib0270","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1074\/jbc.M207335200","article-title":"Targeted replacement of mouse apolipoprotein A-I with human ApoA-I or the mutant ApoA-IMilano. Evidence of APOA-IM impaired hepatic secretion","volume":"278","author":"Parolini","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.05.001_bib0275","doi-asserted-by":"crossref","first-page":"G1067","DOI":"10.1152\/ajpgi.00194.2005","article-title":"Phosphatidylcholine transfer protein regulates size and hepatic uptake of high-density lipoproteins","volume":"289","author":"Wu","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.phrs.2016.05.001_bib0280","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1016\/S0021-9258(20)81987-5","article-title":"Rat intestine secretes spherical high density lipoproteins","volume":"258","author":"Forester","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.05.001_bib0285","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1161\/01.ATV.0000089328.23279.3F","article-title":"Effects of intravenous apolipoprotein A-I\/phosphatidylcholine discs on LCAT, PLTP, and CETP in plasma and peripheral lymph in humans","volume":"23","author":"Kujiraoka","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2016.05.001_bib0290","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/01.ATV.17.2.383","article-title":"Remodeling and shuttling. Mechanisms for the synergistic effects between different acceptor particles in the mobilization of cellular cholesterol","volume":"17","author":"Rodrigueza","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"Suppl","key":"10.1016\/j.phrs.2016.05.001_bib0295","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0021-9150(97)00312-2","article-title":"Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes","volume":"137","author":"Phillips","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2016.05.001_bib0300","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/bbrc.1997.6286","article-title":"Activation of lecithin cholesterol acyltransferase by a disulfide-linked apolipoprotein A-I dimer","volume":"232","author":"Calabresi","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2016.05.001_bib0305","doi-asserted-by":"crossref","first-page":"32168","DOI":"10.1016\/S0021-9258(18)31616-8","article-title":"Molecular characterization of native and recombinant apolipoprotein A-IMilano dimer: the introduction of an interchain disulfide bridge remarkably alters the physicochemical properties of apolipoprotein A-I","volume":"269","author":"Calabresi","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.05.001_bib0310","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1194\/jlr.M001875","article-title":"Analysis of lipid transfer activity between model nascent HDL particles and plasma lipoproteins: implications for current concepts of nascent HDL maturation and genesis","volume":"51","author":"Bailey","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2016.05.001_bib0315","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0022-2275(20)39763-7","article-title":"Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT","volume":"36","author":"Forte","year":"1995","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2016.05.001_bib0320","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0022-2275(20)33491-X","article-title":"Hepatic lipase promotes the selective uptake of high density lipoprotein-cholesteryl esters via the scavenger receptor B1","volume":"40","author":"Lambert","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2016.05.001_bib0325","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.atherosclerosis.2012.02.014","article-title":"Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol","volume":"222","author":"Grefhorst","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2016.05.001_bib0330","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1210\/er.2001-0037","article-title":"The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues","volume":"24","author":"Rigotti","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.phrs.2016.05.001_bib0335","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1194\/jlr.M033779","article-title":"Effect of repeated apoA-IMilano\/POPC infusion on lipids, (apo)lipoproteins, and serum cholesterol efflux capacity in cynomolgus monkeys","volume":"54","author":"Kempen","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2016.05.001_bib0340","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1194\/jlr.R024513","article-title":"Lecithin cholesterol acyltransferase: old friend or foe in atherosclerosis?","volume":"53","author":"Kunnen","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2016.05.001_bib0345","doi-asserted-by":"crossref","first-page":"11715","DOI":"10.1074\/jbc.M112320200","article-title":"Oxidative stress is markedly elevated in lecithin:cholesterol acyltransferase-deficient mice and is paradoxically reversed in the apolipoprotein E knockout background in association with a reduction in atherosclerosis","volume":"277","author":"Ng","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.05.001_bib0350","doi-asserted-by":"crossref","first-page":"17809","DOI":"10.1074\/jbc.M110.180893","article-title":"Lecithin cholesterol acyltransferase null mice are protected from diet-induced obesity and insulin resistance in a gender-specific manner through multiple pathways","volume":"286","author":"Li","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.05.001_bib0355","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0021-9150(98)00058-6","article-title":"Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states","volume":"139","author":"James","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2016.05.001_bib0360","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1161\/01.ATV.19.2.378","article-title":"Inhibition of arterial thrombus formation by ApoA1 Milano","volume":"19","author":"Li","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2016.05.001_bib0365","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1161\/01.CIR.0000074042.19447.B1","article-title":"Intramural delivery of recombinant apolipoprotein A-IMilano\/phospholipid complex (ETC-216) inhibits in-stent stenosis in porcine coronary arteries","volume":"107","author":"Kaul","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.05.001_bib0370","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1177\/009286159502900324","article-title":"Assessment of dose proportionality: report from the statisticians in the Pharmaceutical Industry\/Pharmacokinetics UK joint working party","volume":"29","author":"Gough","year":"1995","journal-title":"Drug Inf. J."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661815301894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661815301894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T20:52:07Z","timestamp":1655671927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661815301894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":74,"alternative-id":["S1043661815301894"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.05.001","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ApoA-IMilano phospholipid complex (ETC-216) infusion in human volunteers. Insights into the phenotypic characteristics of ApoA-IMilano carriers","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}